ArticleInternational journal of hematology2020
Pembrolizumab plus lenalidomide and dexamethasone in treatment-naive multiple myeloma (KEYNOTE-185): subgroup analysis in Japanese patients.
Naoki Takezako et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papertrialcites it